Clinical Features and Outcomes of Serotype 19A Invasive Pneumococcal Disease in Calgary, Alberta
BACKGROUND: Streptoccocus pneumoniae serotype 19A (ST19A) became an important cause of invasive pneumococcal disease (IPD) after the introduction of the conjugate vaccine.
Saved in:
Main Authors: | Leah J Ricketson, Otto G Vanderkooi, Melissa L Wood, Jenine Leal, James D Kellner |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2014-01-01
|
Series: | Canadian Journal of Infectious Diseases and Medical Microbiology |
Online Access: | http://dx.doi.org/10.1155/2014/196748 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Intravenous to Oral Antimicrobial Stepdown Implementation at the Calgary General Hospital, Calgary, Alberta
by: L Heule, et al.
Published: (1995-01-01) -
Solar Energy Modelling over a Residential Community in the City of Calgary, Alberta, Canada
by: Quazi K. Hassan, et al.
Published: (2011-01-01) -
Temporal Variations among Invasive Pneumococcal Disease Serotypes in Children and Adults in Germany (1992–2008)
by: Matthias Imöhl, et al.
Published: (2010-01-01) -
Population-Based Surveillance for Hypermucoviscosity Klebsiella pneumoniae Causing Community-Acquired Bacteremia in Calgary, Alberta
by: Gisele Peirano, et al.
Published: (2013-01-01) -
Adamantane Resistance in Seasonal Human Influenza A Viruses from Calgary, Alberta (January 2007 to August 2008)
by: Kanti Pabbaraju, et al.
Published: (2010-01-01)